OraSure signals revenue ramp in H2 2026 with two FDA-submitted diagnostics launches
Source: SeekingAlpha
2026-02-25 20:18:18 ET
More on OraSure Technologies
- Altai Capital nominates two directors to OraSure's board (update)
- Altai Capital plans to nominate two directors to OraSure's board
- Seeking Alpha’s Quant Rating on OraSure Technologies
- Historical earnings data for OraSure Technologies
- Financial information for OraSure Technologies
Read the full article on Seeking Alpha
For further details see:
OraSure signals revenue ramp in H2 2026 with two FDA-submitted diagnostics launches
OraSure Technologies Inc.
NASDAQ: OSUR
OSUR Trading
2.21% G/L:
$3.01 Last:
239,413 Volume:
$2.88 Open:
OSUR Latest News
February 09, 2026 04:15:00 pm
OraSure to Announce Fourth Quarter 2025 Financial Results and Host Earnings Call on February 25th
OSUR Stock Data
$205,516,563
69,294,590
0.96%
40
N/A
Medical Equipment & Supplies
Healthcare
US
Bethlehem
